학술논문

A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose-expansion cohort
Document Type
Article
Source
In: American Journal of Hematology. (American Journal of Hematology, 1 April 2021, 96(4):428-435)
Subject
Language
English
ISSN
10968652
03618609